Abnormal steroidogenesis and aromatase activity in preeclampsia - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Placenta Année : 2018

Abnormal steroidogenesis and aromatase activity in preeclampsia

Abnormal steroidogenesis and aromatase activity in preeclampsia.

Nadia Berkane
  • Fonction : Auteur
  • PersonId : 911527
Pierre Galichon
  • Fonction : Auteur
  • PersonId : 919075
Tabassome Simon
Alexandre Hertig

Résumé

Introduction : Estrogens and progesterone play critical roles in angiogenesis and vasodilation. Moreover, placental aromatase deficiency is detected in women with preeclampsia (PE) at delivery. We hypothesized that abnormal steroidogenesis occurs much earlier than typical PE diagnosis. Thus, we investigated whether the circulating steroid profile was already disturbed at 24–29 weeks of gestation in women with subsequent PE, and compared the profile with that of women with “placental” small gestational age (SGA) without PE. Methods : We selected nulliparous women (n = 90) from the MOMA trial, including women with PE (n = 25), SGA (n = 25), and controls (NP; n = 40), for plasma steroid profiling by gas chromatography/mass spectrometry and to measure placental growth factor and soluble fms-like tyrosine kinase-1. Placental aromatase expression was evaluated in a new set of women. Results : Compared with that of controls, the women with PE had a significantly lower estrone/androstenedione ratio, and exhibited a decreasing trend for estradiol and estrone levels. Lower estriol levels were observed in the SGA group compared to the NP group. Compared with that of controls, the women with PE and SGA had significantly higher levels of 20α-dihydroprogesterone (20α-DHP) and 20α-DHP/progesterone ratios. Pregnenolone sulfate levels were lower in the PE group than in the NP and SGA groups. Decreased expression of aromatase was observed in the PE group compared to the control group. Discussion : Preeclampsia appears to be characterized by specific steroidogenesis dysregulation long before PE diagnosis, highlighting potential new biomarkers of PE..
Fichier non déposé

Dates et versions

hal-02384945 , version 1 (28-11-2019)

Identifiants

Citer

Nadia Berkane, Philippe Liere, Guillaume Lefèvre, Nadia Alfaidy, Roland Abi Nahed, et al.. Abnormal steroidogenesis and aromatase activity in preeclampsia. Placenta, 2018, 69, pp.40-49. ⟨10.1016/j.placenta.2018.07.004⟩. ⟨hal-02384945⟩
117 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More